Indeed, Oikonomopoulou et al. found that only a very small proportion of immunoreactive KLK6 in ascites fluids of ovarian cancer is active due to the presence of multiple serine protease inhibitors [50]. This evidence concerns the gene KLK6 and ovarian carcinoma.